Dubé, Eve
Trottier, Marie-Eve
Vivion, Maryline
Ouakki, Manale
Brousseau, Nicholas
Guay, Maryse
Laghdir, Zineb
Boucoiran, Isabelle
Tapiéro, Bruce
Quach, Caroline
Article History
Received: 11 April 2022
Accepted: 3 June 2022
First Online: 13 June 2022
Declarations
:
: All methods were performed in accordance with the relevant guidelines and regulations. Study was approved by the Centre hospitalier universitaire Sainte-Justine Research Ethics Board (MP-21-2019-2082) and the CIUSSS-CN ethic board (MEO-21-2019-1767). Each participant gave an informed written consent by signing a consent form. Data anonymization was done after collecting data. Participants who completed the two surveys were eligible to a draw for an Ipad or a gift card from a children’s clothing store.
: Not applicable.
: Bruce Tapiéro received research grants from Merck, GSK, Pfizer, and Sanofi. Nicholas Brousseau was a sub-investigator in a clinical trial on a CMV vaccine (no personal fees) financially supported by Merck & Co.Isabelle Boucoiran is sub-investigator in clinical trials on RSV vaccine (no personal fees) financially supported by Pfizer and GSK. She is recipient of a salary award (chercheur-boursier) from FRQ-S (Quebec’s Health research Fund).All other authors have no competing interests to declare.